- Laboratory >
- Laboratory medicine >
- JAK2 mutation test kit
JAK2 mutation test kits
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
![JAK2 mutation test kit](https://img.medicalexpo.com/images_me/photo-m2/128228-20302642.jpg)
... DNA (see figure JAK2 mutation site identification). The kit provides high levels of sensitivity and reproducibility. The ipsogen JAK2 ...
![JAK2 mutation detection kit](https://img.medicalexpo.com/images_me/photo-m2/4580033-18835452.jpg)
This kit is used to detect the JAK2 gene V617F mutation (COSM12600, c.1849G>T) in DNA samples extracted from tissue and cfDNA samples obtained from plasma. The JAK2 ...
![lung cancer test kit](https://img.medicalexpo.com/images_me/photo-m2/125005-17482269.jpg)
Result display time: 90 min
... Principles: This kit is a nucleic acid amplifcation test for the qualitative detection of ROS1 gene fusions in NSCLC FFPE samples. The kit is based on three major processes: (1) specimen ...
![genetic mutation detection kit](https://img.medicalexpo.com/images_me/photo-m2/302845-18625444.jpg)
Specificity: 100 %
Janus kinase 2 (JAK2) is a non-receptor tyrosine kinase. The V617F mutation in the JAK2 gene involves a valine to phenylalanine amino ...
![cancer test kit](https://img.medicalexpo.com/images_me/photo-m2/91457-17014803.jpg)
JAK2 V617F mutation is found in patients with blood related disease such as Polycythemia Vera, Essential Thrombocythemia and Myelofibrosis. Ruxolitinib is effective as a JAK ...
Your suggestions for improvement:
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining